Browsing by Author "Probstfield, Jeffrey"

Now showing items 1-2 of 2

    • Rivaroxaban with or without aspirin in stable cardiovascular disease 

      Eikelboom, John W.; Connolly, Stuart J.; Bosch, Jackie; Dagenais, Gilles R.; Hart, Robert G.; Shestakovska, Olga; Diaz, Rafael; Alings, Marco; Lonn, Eva M.; Anand, Sonia S.; Widimsky, Petr; Hori, Masatsugu; Avezum, Alvaro; Piegas, Leopoldo S.; Branch, Kelley R.H.; Probstfield, Jeffrey; Bhatt, Deepak L.; Zhu, Jun; Liang, Yan; Maggioni, Aldo P.; Lopez-Jaramillo, Patricio; O’Donnell, Martin; Kakkar, Ajay; Fox, Keith A.A.; Parkhomenko, Alexander N.; Ertl, Georg; Störk, Stefan; Keltai, Matyas; Ryden, Lars; Pogosova, Nana; Dans, Antonio L.; Lanas, Fernando; Commerford, Patrick J.; Torp-Pedersen, Christian; Guzik, Tomek J.; Verhamme, Peter B.; Vinereanu, Dragos; Kim, Jae-Hyung; Tonkin, Andrew M.; Lewis, Basil S.; Felix, Camilo; Yusoff, Khalid; Steg, P. Gabriel; Metsarinne, Kaj P.; Cook Bruns, Nancy; Misselwitz, Frank; Chen, Edmond; Leong, Darryl; Yusuf, Salim (New England Journal of Medicine (NEJM/MMS), 2017-08-27)
      BACKGROUND We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS In this double-blind trial, we randomly assigned ...

    • Urinary sodium and potassium excretion and risk of cardiovascular events 

      O'Donnell, Martin J.; Yusuf, Salim; Mente, Andrew; Gao, Peggy; Mann, Johannes F.; Teo, Koon; McQueen, Matthew; Sleight, Peter; Sharma, Arya M.; Dans, Antonio; Probstfield, Jeffrey; Schmieder, Roland E. (American Medical Association (AMA), 2011-11-23)
      Context The precise relationship between sodium and potassium intake and cardiovascular (CV) risk remains uncertain, especially in patients with CV disease. Objective To determine the association between estimated urinary ...